Type 2 diabetes with sexual dysfunction?. Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
Intervention 1: The intervention group consumes 500 mg herbal tablets three times a day. The drug is prescribed to patients for 8 weeks by a non-researcher, based on masking. The raw materials of this
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 55 Years
Inclusion criteria
Inclusion criteria: Married women with type 2 diabetes and sexual dysfunction HBA1C between 7.1 & 8.53. Age between 25 & 55 years diabetic patients should not have systemic diseases such as liver failure, kidney failure, heart failure, thyroid failure, central nervous system disorders, or retinopathy. Absence of pregnancy and breastfeeding Absence of Ovariectomy history and Ovarian agenesis Having a stable life with his wife Married for at least one year
Exclusion criteria
Exclusion criteria: Diagnosis of having chronic diseases affecting sexual function in the patient or his partner during the study (such as cardiovascular or mental or thyroid disorders, cancers) taking drugs that affect sexual performance The occurrence of an unfortunate incident such as the loss of partner or close relative during the study vaginal bleeding, dyspareunia, vaginismus Getting pregnant Menopause
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: At the beginning of the study and after two months of taking the drug. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| FBS. Timepoint: At the beginning of the study and 60 days after starting to take the drug. Method of measurement: Lab test.;2 hours post prandial blood sugar. Timepoint: At the beginning of the study and 60 days after starting to take the drug. Method of measurement: Lab test.;HB A1C. Timepoint: At the beginning of the study and 60 days after starting to take the drug. Method of measurement: Lab test.;Mental health. Timepoint: At the beginning of the study and 60 days after starting to take the drug. Method of measurement: questionare. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh shirvanizadeh Arani
Yazd University of Medical Sciences
Outcome results
None listed